GRAIL, Inc. (GRAL)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$60.23
+3.33%
Mkt Cap $2.51B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (12 analysts)
$77.33
Range $54.00 – $130.00
Implied Upside
+28.4%
Consensus $77.33 vs current $60.23
NASDAQ·Healthcare·Medical - Diagnostics & Research
$60.23
+3.33%
Mkt Cap $2.51B
Buy
5
Hold
2
Sell
0
Price Target (12 analysts)
$77.33
Range $54.00 – $130.00
+28.4%
Consensus $77.33 vs current $60.23